Goldman Sachs’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-22,084
| Closed | -$4.2K | – | 5119 |
|
2023
Q2 | $4.2K | Buy |
22,084
+2,100
| +11% | +$399 | ﹤0.01% | 4851 |
|
2023
Q1 | $6.8K | Hold |
19,984
| – | – | ﹤0.01% | 4987 |
|
2022
Q4 | $6.46K | Sell |
19,984
-1,238
| -6% | -$400 | ﹤0.01% | 4983 |
|
2022
Q3 | $9K | Sell |
21,222
-2,560
| -11% | -$1.09K | ﹤0.01% | 5270 |
|
2022
Q2 | $10K | Sell |
23,782
-123
| -0.5% | -$52 | ﹤0.01% | 5522 |
|
2022
Q1 | $30K | Sell |
23,905
-477
| -2% | -$599 | ﹤0.01% | 5551 |
|
2021
Q4 | $32K | Buy |
24,382
+1
| +0% | +$1 | ﹤0.01% | 5410 |
|
2021
Q3 | $50K | Sell |
24,381
-24,355
| -50% | -$49.9K | ﹤0.01% | 5192 |
|
2021
Q2 | $77K | Buy |
48,736
+20,236
| +71% | +$32K | ﹤0.01% | 5183 |
|
2021
Q1 | $63K | Buy |
28,500
+3,028
| +12% | +$6.69K | ﹤0.01% | 5105 |
|
2020
Q4 | $63K | Buy |
25,472
+1,858
| +8% | +$4.6K | ﹤0.01% | 4527 |
|
2020
Q3 | $58K | Sell |
23,614
-630
| -3% | -$1.55K | ﹤0.01% | 4308 |
|
2020
Q2 | $86K | Sell |
24,244
-136,752
| -85% | -$485K | ﹤0.01% | 4198 |
|
2020
Q1 | $377K | Buy |
160,996
+119,718
| +290% | +$280K | ﹤0.01% | 3638 |
|
2019
Q4 | $91K | Buy |
41,278
+8,900
| +27% | +$19.6K | ﹤0.01% | 4141 |
|
2019
Q3 | $59K | Sell |
32,378
-125,787
| -80% | -$229K | ﹤0.01% | 4108 |
|
2019
Q2 | $229K | Buy |
158,165
+99,580
| +170% | +$144K | ﹤0.01% | 3821 |
|
2019
Q1 | $115K | Buy |
58,585
+15,135
| +35% | +$29.7K | ﹤0.01% | 3996 |
|
2018
Q4 | $57K | Sell |
43,450
-7,001
| -14% | -$9.18K | ﹤0.01% | 3960 |
|
2018
Q3 | $124K | Buy |
50,451
+7,246
| +17% | +$17.8K | ﹤0.01% | 3909 |
|
2018
Q2 | $145K | Buy |
43,205
+30,502
| +240% | +$102K | ﹤0.01% | 3952 |
|
2018
Q1 | $54K | Buy |
+12,703
| New | +$54K | ﹤0.01% | 4079 |
|
2017
Q4 | – | Sell |
-13,931
| Closed | -$53K | – | 4348 |
|
2017
Q3 | $53K | Sell |
13,931
-12,725
| -48% | -$48.4K | ﹤0.01% | 4114 |
|
2017
Q2 | $117K | Buy |
+26,656
| New | +$117K | ﹤0.01% | 4107 |
|
2015
Q4 | – | Sell |
-10,487
| Closed | -$36K | – | 4652 |
|
2015
Q3 | $36K | Buy |
+10,487
| New | +$36K | ﹤0.01% | 4391 |
|